Innate Pharma SA
Franceline GUILLOT is a highly skilled research and development engineer specializing in immuno-pharmacology, with a significant tenure at Innate Pharma since August 2016. Prior experiences include working as a research engineer at the Centre de Recherche de Cancérologie de Lyon from September 2014 to July 2016 and as a laboratory technician in various medical laboratories. Franceline's background includes expertise in molecular pathology, tumor therapeutic targeting, and the characterization of therapeutic monoclonal antibodies. Educational qualifications include a diploma in biological engineering from Polytech Marseille and a state diploma in medical laboratory technology from Université catholique de Lyon.
This person is not in any teams
This person is not in any offices
Innate Pharma SA
2 followers
Innate Pharma SA is a France-based biopharmaceutical Company that develops drugs for treatment of cancer and inflammatory diseases. The Company identifies and characterizes drug candidates, selects indications and manages the pre-clinical and clinical development of products. Innate Pharma primarily focuses on the development of new therapeutic solutions and monoclonal antibodies for the treatment of cancer, as well as for the treatment of infectious diseases and chronic inflammatory pathologies. The Company develops two categories of immunotherapies: immuno-modulators and cytotoxic antibodies. The Company works in collaboration with Bristol-Myers Squibb for Phase I cancer antibody program and with Novo Nordisk A/S for two antibody programs in inflammation treatment. The Company operates through anti-NKG2A antibody, an immune checkpoint inhibitor ready for Phase II development in oncology from Novo Nordisk.